Type
- ARTG (272)
- Cancellation by sponsor (187)
- Australian Public Assessment Report (AusPAR) (11)
- Prescription medicine registration (10)
- Section 14, TGO91 consent (10)
- Listed medicine compliance report (9)
- Prescription medicine decision summary (4)
- Designation or determination (1)
- Prescription medicine evaluation (1)
Date
- 2024 (25)
- 2023 (60)
- 2022 (44)
- 2021 (30)
- 2020 (41)
- 2019 (37)
- 2018 (14)
- 2017 (37)
- 2016 (9)
- 2015 (42)
- 2014 (24)
- 2013 (6)
- 2012 (15)
- 2011 (6)
- 2010 (7)
- 2009 (3)
- 2008 (9)
- 2007 (7)
- 2006 (5)
- 2004 (7)
- 2003 (6)
- 2002 (4)
- 2001 (3)
- 2000 (9)
- 1999 (1)
- 1998 (7)
- 1997 (2)
- 1996 (5)
- 1995 (2)
- 1994 (7)
- 1993 (3)
- 1992 (6)
- 1991 (22)
Results for
"[search-keyword]"
Sponsor content
505 result(s) found, displaying 81 to 90
-
Cancellation by sponsorRequested by Bayer Australia Ltd
-
Cancellation by sponsorRequested by Bayer Australia Ltd
-
Cancellation by sponsorRequested by Bayer Australia Ltd
-
Cancellation by sponsorRequested by Bayer Australia Ltd
-
Prescription medicine decision summaryTGA decision: Jivi (damoctocog alfa pegol) is approved to treat adults and adolescents (12 years of age and older) with haemophilia A
-
Cancellation by sponsorRequested by Bayer Australia Ltd
-
Cancellation by sponsorRequested by Bayer Australia Ltd
-
Cancellation by sponsorRequested by Bayer Australia Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Elevit Infant Bone and Teeth Support Liquid Calcium.
-
Prescription medicine registrationActive ingredients: damoctocog alfa pegol, water for injections.